Clinical trials: Potentially Operable Lung Tumor
For Oncologic Patients, Potentially Operable Lung Tumor
DECT Ventilation Imaging
Demonstrate the feasibility of dual energy computed tomography using Krypton as a gaseous contrast media in order to study the in vivo ventilation.
- Conditions
- For Oncologic Patients, Potentially Operable Lung Tumor, With a Recent (Less Than 1 Month) VQ Scan, For Lung Transplant Recipients
- Trial name
- NCT02377518
- Testing
- Single source dual energy compted tomography (CT750HD, General Electric, USA) with Krypton as a gaseous contrast media
- Where
- France
- Volunteers
- 10 people
- Sponsor
- University Hospital, Strasbourg, France
ALK-positive Advanced NSCLC, ALK-positive Non-small Cell Lung Cancer (NSCLC)
Efficacy and Safety of Ensartinib in Neoadjuvant Therapy for Stage IIA - IIIB (Operable or Potentially Operable) ALK-Positive Lung Adenocarcinoma ：A Multicenter, Real-World Clinical Study
According to the Global Cancer Statistics 2022 report, lung cancer is the most common type of cancer (12.4% of the total) and the leading cause of cancer deaths (18.7% of total cancer deaths).
- Conditions
- ALK-positive Advanced NSCLC, ALK-positive Non-small Cell Lung Cancer (NSCLC), MPR, Neoadjuvant Therapy
- Trial name
- NCT06785584
- Testing
- Ensartinib
- Where
- China
- Volunteers
- 30 people
- Sponsor
- Fujian Medical University Union Hospital
Non-small Lung Cancer
Toripalimab Combined With SBRT for NSCLC
This study aimed to evaluate the efficacy and safety of Toripalimab injection (js001) combined with SBRT radiotherapy and neoadjuvant therapy with or without chemotherapy for operable or potentially operable stage IIa to IIIb…
- Trial name
- NCT06293690
- Testing
- Toripalimab
- Where
- China
- Volunteers
- 40 people
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
Lung Cancer
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
RATIONALE: Imaging procedures, such as positron emission tomography (PET), may improve the ability to detect the extent of non-small cell lung cancer.
- Trial name
- NCT00004138
- Testing
- positron emission tomography, radionuclide imaging, fludeoxyglucose F 18
- Where
- 23 sites in United States
- Volunteers
- 303 people
- Sponsor
- Alliance for Clinical Trials in Oncology
Lung Cancer
Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer
RATIONALE: Drugs used in chemotherapy (CT), such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.
- Trial name
- NCT00979212
- Testing
- panitumumab, carboplatin, paclitaxel
- Where
- 31 sites in United States
- Volunteers
- 71 people
- Sponsor
- Radiation Therapy Oncology Group
Lung Cancer
Mediastinal Staging of Lung Cancer With EBUS-TBNA and EUS-B-FNA
The purpose of this study is to find a role of EUS-B-FNA in the mediastinal staging of potentially operable lung cancer. The investigators perform EBUS-TBNA and EUS-B-FNA on potentially operable lung cancer patients.
- Trial name
- NCT00741247
- Testing
- EBUS-TBNA, EUS-B-FNA (EUS-FNA with bronchoscope)
- Where
- South Korea
- Volunteers
- 150 people
- Sponsor
- National Cancer Center, Korea